Journal article
Clinical management of Australian adolescents and young adults with acute lymphoblastic and myeloid leukemias: A national population-based study
VM White, G Skaczkowski, R Pinkerton, M Coory, M Osborn, H Bibby, W Nicholls, LM Orme, R Conyers, MB Phillips, R Harrup, R Walker, K Thompson, A Anazodo
Pediatric Blood and Cancer | WILEY | Published : 2018
DOI: 10.1002/pbc.27349
Abstract
Background: While several studies have examined the treatment of adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL), studies of acute myeloid leukemia (AML) are rare. Using national data for Australia, we describe (i) the number and type of treatment centers caring for AYAs, (ii) induction/first-line treatments, and (iii) survival outcomes. Procedure: National population-based study assessing treatment of 15- to 24-year-olds diagnosed with ALL or AML between 2007 and 2012. Treatment details were abstracted from hospital medical records. Treatment centers were classified as pediatric or adult (adult AYA-focused or other adult; and by AYA volume [high/low]). Cox propor..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
This work was supported by the National Health and Medical Research Council of Australia (NHMRC) project grant 1012250 and grants from CanTeen Australia and The Kids Cancer Project.